Financial Advocates Investment Management’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,000
| Closed | -$148K | – | 618 |
|
|
2025
Q1 | $148K | Buy |
51,000
+1,000
| +2% | +$2.9K | 0.01% | 686 |
|
|
2024
Q4 | $178K | Buy |
50,000
+11,000
| +28% | +$39.2K | 0.01% | 704 |
|
|
2024
Q3 | $194K | Buy |
39,000
+5,000
| +15% | +$24.9K | 0.01% | 713 |
|
|
2024
Q2 | $88.4K | Buy |
34,000
+14,000
| +70% | +$36.4K | 0.01% | 698 |
|
|
2024
Q1 | $85.2K | Hold |
20,000
| – | – | ﹤0.01% | 734 |
|
|
2023
Q4 | $40.4K | Hold |
20,000
| – | – | ﹤0.01% | 717 |
|
|
2023
Q3 | $30.6K | Hold |
20,000
| – | – | ﹤0.01% | 688 |
|
|
2023
Q2 | $33K | Sell |
20,000
-5,000
| -20% | -$8.25K | ﹤0.01% | 687 |
|
|
2023
Q1 | $28.5K | Sell |
25,000
-7,000
| -22% | -$7.98K | ﹤0.01% | 722 |
|
|
2022
Q4 | $28.9K | Buy |
32,000
+5,000
| +19% | +$4.51K | ﹤0.01% | 735 |
|
|
2022
Q3 | $32K | Hold |
27,000
| – | – | ﹤0.01% | 732 |
|
|
2022
Q2 | $17K | Buy |
27,000
+7,500
| +38% | +$4.72K | ﹤0.01% | 675 |
|
|
2022
Q1 | $51K | Hold |
19,500
| – | – | ﹤0.01% | 714 |
|
|
2021
Q4 | $76K | Buy |
19,500
+2,500
| +15% | +$9.74K | ﹤0.01% | 747 |
|
|
2021
Q3 | $74K | Hold |
17,000
| – | – | 0.01% | 728 |
|
|
2021
Q2 | $67K | Buy |
17,000
+4,000
| +31% | +$15.8K | ﹤0.01% | 710 |
|
|
2021
Q1 | $68K | Sell |
13,000
-1,200
| -8% | -$6.28K | ﹤0.01% | 722 |
|
|
2020
Q4 | $76K | Buy |
+14,200
| New | +$76K | 0.01% | 699 |
|